← FDA Drug Approvals (Drugs@FDA)

LIRAGLUTIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SANDOZ · Approved 2026-07-01

Drug application

FDA Application #

ANDA212972

Application type

Abbreviated New Drug Application (Generic)

Brand name

LIRAGLUTIDE

Generic name

Liraglutide

Active ingredients

LIRAGLUTIDE

Dosage form

SOLUTION

Route

SUBCUTANEOUS

Marketing status

Prescription

Sponsor

SANDOZ

First approval

2026-07-01

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown